-

Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of CURO Group Holdings, Corp. (CURO)

SAN DIEGO & WICHITA, Kan.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that it is investigating the officers and directors of CURO Group Holdings, Corp. (NYSE: CURO) for breaches of fiduciary duties, unjust enrichment, and violations of the Securities Exchange Act of 1934. CURO is a diversified consumer finance company, provides consumer finance to a range of underbanked consumers.

If you suffered a loss as a result of CURO's misconduct, click here.

CURO Group Holdings, Corp. (CURO) Sued for Misleading Shareholders About FY 2018 Guidance

Shareholders filed a securities fraud class action against CURO, alleging that between April 27, 2018 and October 24, 2018, defendants materially misrepresented to investors the negative effect that the rapid transition from payday loans to open-end loans, along with other changes, was having on the company's financial performance and 2018 full-year company guidance. The false statements caused CURO stock to trade at artificially inflated prices – as high as $31 per share. However, as the truth of the wrongdoing was revealed the stock plummeted to $15.18 per share.

CURO challenged these allegations and on December 3, 2019, U.S. District Court Judge John W. Lungstrum denied CURO's motion to dismiss plaintiffs' claims, stating that the facts supported the notion that CURO's executives "were at least reckless in failing to disclose that the decision to accelerate the transition would call into question the accuracy of the 2018 guidance." The Court’s denial of CURO's motion to dismiss could result in substantial financial damage to CURO as litigation proceeds.

CURO Group Holdings, Corp. (CURO) Shareholders Have Legal Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against CURO settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

CPNG Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against Coupang, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Coupang, Inc. (NYSE: CPNG) securities between April 6, 2025 and December 16, 2025. Coupang describes itself as one of the fastest-growing technology and commerce companies in the world, providing retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Cou...

Did You Lose Money in SFM? Stockholders Who Incurred Significant Financial Loss in Sprouts Farmers Market, Inc. Should Contact Robbins LLP to Learn About Leading the SFM Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Sprouts Farmers Market, Inc. (NASDAQ: SFM) is a specialty grocery store chain that operates in the U.S. What is the class period? June 4, 2025 - October 29, 2025. What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Sprouts Farmers Market, Inc. during the class period because the Company allegedly misled investors regarding its growth potential. For...

MCTA Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Securities Class Action Against Charming Medical, Limited

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Charming Medical, Limited (NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025. The Company claims to “enhance[] the quality of life from the inside out by integrating Traditional Chinese Medicine (TCM) wellness practices with modern technology.” For more information, submit a form, email attorney Aaron Dumas, Jr., or give...
Back to Newsroom